142 related articles for article (PubMed ID: 38308838)
1. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
Xin Y; Bai Y; Jiang X; Zhou S; Wang Y; Wintergerst KA; Cui T; Ji H; Tan Y; Cai L
Redox Biol; 2018 May; 15():405-417. PubMed ID: 29353218
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway.
Xu C; Xia L; Xu D; Liu Y; Jin P; Zhai M; Mao Y; Wang Y; Wen A; Yang J; Yang L
J Cell Mol Med; 2024 Jan; 28(2):e18055. PubMed ID: 38113341
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
9. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
10. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
11. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
12. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation.
Hao J; Zhou J; Hu S; Zhang P; Wu H; Yang J; Zhao B; Liu H; Lin H; Chi J; Lou D
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C331-C347. PubMed ID: 38047307
[TBL] [Abstract][Full Text] [Related]
13. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
[TBL] [Abstract][Full Text] [Related]
14. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
15. Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway.
Liu Y; Zhao YB; Wang SW; Zhou Y; Tang ZS; Li F
Int J Mol Med; 2017 Sep; 40(3):913-921. PubMed ID: 28677741
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
[TBL] [Abstract][Full Text] [Related]
17. Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway.
Ma W; Guo W; Shang F; Li Y; Li W; Liu J; Ma C; Teng J
Oxid Med Cell Longev; 2020; 2020():3732718. PubMed ID: 33062139
[TBL] [Abstract][Full Text] [Related]
18. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
[TBL] [Abstract][Full Text] [Related]
19. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
[TBL] [Abstract][Full Text] [Related]
20. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]